Delivering quality therapy since 1901

Areas of Interest

We are actively seeking to expand our pipeline and product portfolio based on the following criteria:

 


License-in (originals)

Women’s Health

Territory: European Union (EU), Russia and Commonwealth of Independent States (CIS), China, Latin-America
We are searching for:clinical phase projects with at least an efficacy signal, registered or marketed products
We offer:co-development and co-financing, registration, participation in P&R approval, sales and marketing


 

Central Nervous System

Territory: European Union (EU), Russia and Commonwealth of Independent States (CIS), China
We are searching for:preclinical and early clinical phase projects (Ph1, Ph2a) in dementia, autism and obesity, registered or marketed products in all CNS indications
We offer:acquisition of early developments, co-development and co-financing, registration, participation in P&R approval, sales and marketing


 


 

Other therapy areas (Cardiovascular, Rheumatology, Respiratory, Anti-infectives), OTC products

Territory: Central and Eastern Europe (CEE), Russia and Commonwealth of Independent States (CIS), China
We are searching for:late-stage clinical phase projects, registered or marketed products
We offer:co-financing, registration, participation in P&R approval, sales and marketing


 

Joint development

We offer early Research and Development collaborations in dementia, migraine prophylaxis, autism and obesity and participation in the design and running of clinical trials in strategically selected areas within the Central Nervous System and Gynecology.


 

Technology transfer & manufacturing

With the ability to manufacture a broad range of finished dosage forms in state of the art EMA and FDA approved facilities in Hungary, Poland, Romania, Russia and Germany Richter is open to discuss manufacturing opportunities of innovative license-in projects. Richter is also actively searching for contract manufacturing opportunities for his state-of-the-art manufacturing facilities with a special emphasis on contract development and manufacturing of steroid APIs and finished dosage forms, and contract manufacturing of microbial and mammalian-cell based biotechnology compounds.